Trials / Completed
CompletedNCT03716076
Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study
The Effect of Carbetocin Dose on Dispersion of Myocardial Repolarization in Healthy Parturients Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Relationship between carbetocin dose on transmural dispersion of repolarization (TDR).
Detailed description
Carbetocin is a uterotonic used to prevent postpartum hemorrhage. Although it has been proven to be completely safe, little is known about its effects on the electrical activity of the heart. The investigators aim to determine its effect on myocardial repolarization dynamics
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbetocin | 50 mcg or 100 mcg bolus of carbetocin |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-06-15
- Completion
- 2020-04-24
- First posted
- 2018-10-23
- Last updated
- 2021-05-14
- Results posted
- 2021-05-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03716076. Inclusion in this directory is not an endorsement.